Accepting PhD Students

PhD projects

Tatjana Stankovic’s research is focused on an elucidation of the role of ataxia telangiectasia mutated (ATM) and other DNA damage response genes in the multistep process of leukaemia/ lymphomagenesis. Particular emphasis is given to DNA damage response defects that can be targeted for tumour-specific treatment. Therefore, a long-term goal is to translate the understanding of DNA damage response pathways in haematopoietic malignancies into novel therapeutic strategies. Current and future studies focus on:

Identification of a network of ATM-dependent cellular responses and DNA repair defects that can be targeted for treatment in chronic leukaemia
Addressing different mechanisms of tumorigenesis and novel therapeutic approaches in mouse models of ATM-deficient haematopoietic malignancies
Studying the effect of histone deacetylase (HDAC) inhibitors and demethylating agents on immune responses in acute myeloid leukaemia (AML)
Identifying activated kinases and DNA repair proteins that cause chemoresistance in paediatric acute lymphoblastic leukaemia (ALL)

19992023

Research activity per year

Network

Paul Moss

Person: Academic

Grant Stewart

Person: Academic

Helen Parry

Person: Academic

Pamela Kearns

Person: Academic

Eva Petermann

Person: Academic

Tracey Perry

Person: Honorary

Andrew Beggs

Person: Academic

Gary Reynolds

Person: Academic, Honorary

Sarah Berhane

Person: Academic

Andrew Bell

Person: Academic

John Reynolds

Person: Honorary

Boris Noyvert

Person: Honorary

Ian Tomlinson

Person: Academic, Honorary

Manoj Raghavan

Person: Academic

Guy E D Pratt

  • University Hospital Birmingham NHS Foundation Trust

External person

David Oscier

  • George Eliot Hospital NHS Trust
  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

External person

Andrew R. Pettitt

  • University of Liverpool
  • The Clatterbridge Cancer Centre NHS Foundation Trust

External person

Ferran Nadeu

  • CSIC/IDIBAPS
  • Centro de Investigación Biomédica en Red de Cáncer

External person

Jonathan C. Strefford

  • University of Southampton

External person

Elias Campo

  • CSIC/IDIBAPS
  • Centro de Investigación Biomédica en Red de Cáncer
  • Hospital Clínic of Barcelona
  • Universitat de Barcelona

External person

Julio Delgado

  • CSIC/IDIBAPS
  • Centro de Investigación Biomédica en Red de Cáncer
  • Hospital Clínic of Barcelona
  • Universitat de Barcelona

External person

Xose S Puente

  • Centro de Investigación Biomédica en Red de Cáncer
  • Universidad de Oviedo

External person

Romina Royo

  • Centro Nacional de Supercomputacion

External person

Stephen Devereux

  • King’s College London

External person

Pauline Robbe

  • University of Oxford
  • RIKEN Center for Integrative Medical Sciences

External person

Samuel J. Clokie

  • Birmingham Women's Hospital NHS Foundation Trust

External person

Mark J Caulfield

  • Queen Mary, University of London
  • Genomics England Limited

External person

Martin A M Reijns

  • University of Edinburgh

External person

Rhiannon E Jones

  • University of Winchester
  • Cardiff University

External person

Laura Magnano

  • CSIC/IDIBAPS
  • Centro de Investigación Biomédica en Red de Cáncer
  • Hospital Clínic of Barcelona

External person

Ruth Clifford

  • University Hospital Limerick
  • University of Limerick
  • University of Oxford

External person

Jadwiga Nieminuszczy

  • University of Oxford

External person

Sarka Pospisilova

  • Masaryk University
  • UHB - University Hospital Brno and Masaryk University

External person

Dragana Janic

  • University of Belgrade

External person

Josep Ll Gelpí

  • Centro Nacional de Supercomputacion
  • Universitat de Barcelona

External person

Pavlos Antoniou

  • Illumina Cambridge Ltd
  • University of Oxford

External person

Dimitrios V. Vavoulis

  • University of Oxford

External person

Andrew G. Leach

  • University of Manchester

External person

Daniel Catovsky

  • Institute for Cancer Research

External person

Olaf Merkel

  • Medical University of Vienna
  • DKFZ (German Cancer Research Centre)
  • European Research Initiative on ALK Related Malignancies (ERIA)

External person

Holger Heyn

  • Barcelona Institute of Science and Technology
  • Pompeu Fabra University

External person

Matthew J J Rose-Zerilli

  • University of Southampton

External person

Malcom A. Taylor

  • University of Birmingham

External person

Anna Schuh

  • University of Oxford

External person

Sara Ruiz-Gil

  • Barcelona Institute of Science and Technology

External person

Andy Rawstron

  • Leeds Teaching Hospitals NHS Trust

External person

Stefan Knapp

  • University of Oxford
  • Trinity College Dublin
  • Structural Genomics Consortium (United Kingdom)
  • Goethe University
  • Buchmann Institute for Molecular Life Sciences

External person

Jade Forster

  • University of Southampton

External person

Zadie Davis

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

External person

Paul A S Evans

  • St. James's University Hospital

External person

Andrew J Steele

  • University of Southampton

External person

Alex J. Cornish

  • Institute for Cancer Research

External person

Helen McCarthy

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

External person

Marta Larrayoz

  • University of Southampton

External person

Maite Cabes

  • John Radcliffe Hospital

External person

Niamh Appleby

  • University of Oxford

External person

Adam Giess

  • Genomics England Limited

External person

Jim Hughes

  • University of Oxford

External person

Ron Schwessinger

  • University of Oxford

External person

Andrew Colins

  • University of Southampton

External person

Stuart J. Blakemore

  • University of Southampton
  • University of Cologne

External person

Fiona Maleady-crowe

  • Genomics England Limited

External person

Latha Kadalyayil

  • University of Southampton

External person

Alicja Winczura

  • University of Oxford

External person

Reem Alsolami

  • King Abdulaziz University

External person

Helen Brittain

  • Genomics England Limited

External person

David Allsup

  • Hull York Medical School

External person

Marcos González

  • Fundación Galileo Galilei-INAF

External person

Triantafillos Liloglou

  • University of Liverpool

External person

Angela Hamblin

  • Genomics England Limited

External person

Chris Pepper

  • Brighton and Sussex Medical School

External person

Martina Seiffert

  • DKFZ (German Cancer Research Centre)

External person

David R Gonzalez De Castro

  • Queen's University, Belfast

External person

Michael McMahon

  • FLIGHT ATTENDANT MEDICAL RESEARCH INSTITUTE
  • University of Dundee

External person

Chris Hudson

  • University of Nottingham

External person

Samantha J. L. Knight

  • University of Oxford

External person

Simon F. Mitchell

  • Brighton and Sussex Medical School

External person

Melis Kayikci

  • Genomics England Limited

External person

Elizabeth H. Phillips

  • King’s College London

External person

Louise Carr

  • University of Southampton

External person

Eve Coulter

  • Queen Mary, University of London
  • King’s College London

External person

Mark Ross

  • Illumina Cambridge Ltd

External person

Basile Stamatopoulos

  • Institut Jules Bordet

External person

Nicholas Denny

  • University of Oxford

External person

Helen E Parker

  • University of Cambridge

External person

Ralph Schulz

  • DKFZ (German Cancer Research Centre)

External person

Anna C. Need

  • Genomics England Limited

External person

Helene Dréau

  • University of Oxford

External person

Federico Minneci

  • Genomics England Limited

External person

Christopher I Jones

  • Brighton and Sussex Medical School

External person

Daniel Chubb

  • Institute for Cancer Research

External person

Emma Kennedy

  • Brighton and Sussex Medical School

External person

Loukas Moutsianas

  • Genomics England Limited

External person

Barnaby Clark

  • King's College Hospital NHS Foundation Trust

External person

Mark S. Cragg

  • University of Southampton

External person

Meriel Mcentagart

  • Genomics England Limited

External person

Farooq A Wandroo

  • Sandwell and West Birmingham Hospitals NHS Trust

External person

X Li

  • University of Nottingham
  • China Institute of Atomic Energy
  • Los Alamos National Laboratory
  • Duke University

External person

Christopher J. Lord

  • The Institute of Cancer Research

External person

Freya Boardman-pretty

  • Genomics England Limited
  • Queen Mary, University of London

External person

Dean Bryant

  • University of Southampton

External person

Jenny Jesson

  • Birmingham Childrens Hospital

External person

Renata J. Walewska

  • The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust

External person

Robert Månsson

  • Karolinska Institutet

External person

Ricardo Morilla

  • Institute for Cancer Research

External person

Doriane Cavalieri

  • CHU de Clermont-Ferrand

External person

Andrew P. Jackson

  • University of Edinburgh
  • Loughborough University
  • Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit

External person

Rosalynd Johnston

  • Brighton and Sussex University Hospital Trust

External person

Tom Fowler

  • Genomics England Limited

External person

Laura Lopez-Pascua

  • UK Health Security Agency

External person

Thomas A. Burley

  • Brighton and Sussex Medical School

External person

Uma Maheswari

  • Illumina Cambridge Ltd

External person

Anthony Cutts

  • University of Oxford

External person

Simon Boulton

  • London Res Inst

External person

Andrea G.S. Pepper

  • Brighton and Sussex Medical School

External person

Javier F. Lopez

  • Genomics England Limited

External person

Kate E. Ridout

  • University of Oxford

External person

Jacqueline Chan

  • Oxford Gene Technology

External person

Nirupa Murugaesu

  • St George's Healthcare NHS Trust
  • Genomics England Limited

External person

Anika V. Prabhu

  • RIKEN Center for Integrative Medical Sciences

External person

Monica Else

  • Institute for Cancer Research

External person

Shirley J Henderson

  • Genomics England Limited

External person

L Pelletier

  • Universite du Quebec a Montreal

External person

Elisabeth Walsby

  • Cardiff University

External person

Christopher R. Boustred

  • Genomics England Limited

External person

José I. Martín-Subero

  • Human Technopole
  • ICREA

External person

Tim J P Hubbard

  • Genomics England Limited

External person

T T Lin

  • Shandong University

External person

Sarah E. A. Leigh

  • Genomics England Limited

External person

K Norris

  • Sheffield Hallam University

External person

Tim Chevassut

  • Brighton and Sussex Medical School
  • Brighton and Sussex University Hospital Trust

External person

Piero Carninci

  • RIKEN
  • Human Technopole

External person

Emma Halliwell

  • Institute of Child Health

External person

Valerie Borel

  • London Res Inst
  • The Francis Crick Institute

External person

Johann De Bono

  • Royal Marsden Hospital
  • Royal Marsden NHS Foundation Trust
  • Institute for Cancer Research

External person

W Wei

  • Fraunhofer-Institut für Lasertechnik ILT

External person

John C. Ambrose

  • Genomics England Limited

External person

Daisy Jennings

  • RIKEN Center for Integrative Medical Sciences

External person

Paul S Hole

  • George Eliot Hospital NHS Trust
  • Institute of Cancer and Genetics
  • Cardiff University

External person

G Davies

  • Great Ormond Street Hospital NHS Foundation Trust

External person

J Aoki

  • Tohoku University
  • Japan Agency for Marine-Earth Science and Technology

External person

Athanasios Kousathanas

  • Genomics England Limited

External person

Adam Burns

  • University of Oxford

External person

Jiayi Lu

  • Karolinska Institutet

External person

PS Short

  • University of Edinburgh

External person

Martí Duran-Ferrer

  • Universitat de Barcelona

External person

Dalia Kasperaviciute

  • Genomics England Limited
  • Queen Mary, University of London

External person

Ivonne U. S. Leong

  • Genomics England Limited

External person

James Davies

  • University of Oxford

External person

Graham Speight

  • Oxford Gene Technology

External person

Steve J Coles

  • George Eliot Hospital NHS Trust
  • Institute of Cancer and Genetics
  • Cardiff University

External person

Richard S. Houlston

  • The Institute of Cancer Research

External person

Melanie Oates

  • University of Liverpool

External person

Roel Bevers

  • Genomics England Limited

External person

Deborah K Dunn-Walters

  • University of Surrey

External person

Marta Bleda

  • Genomics England Limited

External person

Georgia C. Chan

  • Genomics England Limited

External person